Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.210
+0.040 (3.42%)
At close: Oct 9, 2026, 4:00 PM EDT
1.200
-0.010 (-0.83%)
After-hours: Oct 9, 2026, 7:45 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $51.55 million as of October 9, 2026. It is the 30,208th most valuable company in the world and the 4,650th biggest in the United States. Its market cap has increased by 16.55% in one year.
Market Cap
51.55M
Enterprise Value
32.82M
1-Year Change
16.55%
Global Rank
Country Rank
#4,650 United States
Category
ChartMarket Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $51.55M, a decrease of -17.53%. That is a compound annual growth rate of -2.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 51.55M | -43.78% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Connect Biopharma Holdings | 54.79M |
| MiNK Therapeutics | 54.70M |
| LeonaBio | 54.17M |
| Hyperion DeFi | 52.83M |
| INmune Bio | 52.45M |
| Serina Therapeutics | 50.80M |
| Celularity | 50.62M |
| Elicio Therapeutics | 49.67M |